Literature DB >> 8470380

Botulinum toxin. From poison to medicine.

L E Davis1.   

Abstract

Although thousands of people in the world each year continue to be poisoned with botulinum toxin-food-borne, infantile, or wound botulism-the neurotoxin is now sufficiently understood to allow it to be used as a medicinal agent to paralyze specific muscles, giving temporary symptomatic relief from a variety of dystonic neurologic disorders. I review some of the epidemiologic, clinical, and pathophysiologic aspects of botulinum toxin and how the neurotoxin may act as a poison or a medicine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8470380      PMCID: PMC1021932     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  48 in total

1.  Food-borne botulism in the United States, 1970-1975.

Authors:  M A Horwitz; J M Hughes; M H Merson; E J Gangarosa
Journal:  J Infect Dis       Date:  1977-07       Impact factor: 5.226

2.  Diagnosis and management of infant botulism.

Authors:  R O Johnson; S A Clay; S S Arnon
Journal:  Am J Dis Child       Date:  1979-06

Review 3.  Infant botulism.

Authors:  S S Arnon
Journal:  Annu Rev Med       Date:  1980       Impact factor: 13.739

4.  Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction.

Authors:  L L Simpson
Journal:  J Pharmacol Exp Ther       Date:  1980-01       Impact factor: 4.030

5.  Pathophysiologic aspects of human botulism.

Authors:  L Gutmann; L Pratt
Journal:  Arch Neurol       Date:  1976-03

6.  Infant botulism. Epidemiological, clinical, and laboratory aspects.

Authors:  S S Arnon; T F Midura; S A Clay; R M Wood; J Chin
Journal:  JAMA       Date:  1977-05-02       Impact factor: 56.272

7.  Quantitative evidence of intestinal colonization by Clostridium botulinum in four cases of infant botulism.

Authors:  B W Wilcke; T F Midura; S S Arnon
Journal:  J Infect Dis       Date:  1980-04       Impact factor: 5.226

8.  Botulism, type A, and treatment with guanidine.

Authors:  J E Kaplan; L E Davis; V Narayan; J Koster; D Katzenstein
Journal:  Ann Neurol       Date:  1979-07       Impact factor: 10.422

9.  Potentiation of neuromuscular weakness in infant botulism by aminoglycosides.

Authors:  C L'Hommedieu; R Stough; L Brown; R Kettrick; R Polin
Journal:  J Pediatr       Date:  1979-12       Impact factor: 4.406

10.  Bacteriophage and the toxigenicity of Clostridium botulinum type C.

Authors:  M W Eklund; F T Poysky; S M Reed; C A Smith
Journal:  Science       Date:  1971-04-30       Impact factor: 47.728

View more
  6 in total

Review 1.  Botulinum toxin in children with cerebral palsy.

Authors:  Pratibha Singhi; Munni Ray
Journal:  Indian J Pediatr       Date:  2004-12       Impact factor: 1.967

Review 2.  [Botulinum toxin in urology. An inventory].

Authors:  H Schulte-Baukloh; H H Knispel
Journal:  Urologe A       Date:  2004-08       Impact factor: 0.639

3.  Efficacy and safety of serial injections of botulinum toxin A in children with spastic cerebral palsy.

Authors:  Ya-Jie Wang; Bao-Qin Gao
Journal:  World J Pediatr       Date:  2013-11-14       Impact factor: 2.764

4.  Treatment of the spasticity in children with cerebral palsy.

Authors:  Ajsa Meholjić-Fetahović
Journal:  Bosn J Basic Med Sci       Date:  2007-11       Impact factor: 3.363

5.  Botulism.

Authors:  Larry E. Davis
Journal:  Curr Treat Options Neurol       Date:  2003-01       Impact factor: 3.598

Review 6.  Toxin yet not toxic: Botulinum toxin in dentistry.

Authors:  M S Archana
Journal:  Saudi Dent J       Date:  2015-12-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.